In lung cancer, forced expression of miR-196a alone induces cell proliferation and inhibits apoptosis by down-regulating GLTP, increasing cell resistance to gefitinib therapy in vitro and in vivo 21. The gene discussed is GLTP; the disease is lung cancer.